Value Analysis Committee Information

To be an effective device for the treatment of a biliary obstruction, precise placement, high patency, and low migration are needed. With its unique combination of features and benefits, GORE® VIABIL® Biliary Endoprosthesis is the only fully covered metal stent with anti-migration technology proven to reduce the risk of reintervention.

Fully covered self-expanding metal stents for endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous cholangiography (PTC) in the management of malignant biliary obstruction: A U.S. cost consequence analysis.

André T. Stevenson Jr., Ph.D. | Frank O’Neill, Ph.D. | Vimal Swarup, Ph.D. | W. L. Gore & Associates

PICO table descriptions

Time frame and setting: Studies published from January 2000 through September 2021 in all countries.

PICO table descriptions

 

To review the full poster, click here: Thumbnail for 22566552-EN-VBL-POSTER-4x6-DDW-2022-FNL.pdf

 

Value Analysis Overview

Anti-migration Assurance Program

The unique anti-migration technology aids in reducing the risk of reinterventions. The fully covered atraumatic anchoring fins securely hold the device within the duct.

  • Average migration rate: 0.9% (0.1% - 1.7%).2
  • GORE® VIABIL® Biliary Endoprosthesis is the only fully covered metal stent with anti-migration technology proven to reduce the risk of reintervention.
  • Replacement device of identical dimensions for use with the patient whose device migrates within one year post implantation.

The extremely low migration rates of the GORE® VIABIL® Short Wire Biliary Endoprosthesis help me limit patients’ risks and keep their quality of life and satisfaction with their outcomes as high as I’m able, and I’m pleased to see that performance now backed by Gore’s cost-reducing Anti-Migration Assurance Program.

Todd Baron, MD, UNC Hospitals GI Medicine Clinic

Endoscopic delivery: Contact your CONMED representative for support and product availability. Visit here for further support.

Percutaneous delivery: Contact your Gore Sales Associate for support and product availability. Visit here for further support.

 

  1. Medicine. 2021;100(3):e23938.
  2. Stevenson AT Jr, O'Neill F, Swarup VP; W. L. Gore & Associates. Fully covered self-expanding metal stents for endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous cholangiography (PTC) in the management of malignant biliary obstruction: a U.S. cost consequence analysis. Flagstaff, AZ: W. L. Gore & Associates, Inc; 2022. [Poster]. 22566552-EN.

22772509-EN

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.